Fuller & Thaler Asset Management, Inc. Inogen Inc Transaction History

Fuller & Thaler Asset Management, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$112.83 - $239.74 $7.59 Million - $16.1 Million	-67,280 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$189.1 - $282.92 $964,599 - $1.44 Million	-5,101 Reduced 7.05%	67,280 $16.4 Million
Q2 2018 Aug 07, 2018	BUY	$123.8 - $192.48 $36,025 - $56,011	291 Added 0.4%	72,381 $13.5 Million
Q1 2018 May 14, 2018	SELL	$114.22 - $133.22 $262,706 - $306,406	-2,300 Reduced 3.09%	72,090 $8.86 Million
Q4 2017 Feb 12, 2018	BUY	$93.4 - $128.74 $6.95 Million - $9.58 Million	74,390	74,390 $8.86 Million

146

20.9M

88.5K

116K

Ticker INGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 22,866,500
Market Cap $155M
Description
Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respirat...

Get notified when there are updates to the investment portfolio of Fuller & Thaler Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Fuller & Thaler Asset Management, Inc. with notifications on news.